Supporting the public health response to coronavirus

USP is working with government organizations, manufacturers of drugs and other health products, and healthcare professionals in the US and around the world to build the public’s trust in vaccines and treatments for COVID-19 disease. Our work includes standards that assure the quality and safety for drug ingredients and finished products, and technical assistance and support on issues such as vaccine administration and raw material selection and testing. We are also addressing supply challenges and emerging quality and safety concerns with medicines and products such as hand sanitizer.

Alcohol-based hand sanitizer information

Changes to the global supply chain have caused an emergence of quality incidents both regionally and globally.

Access hand sanitizer toolkit

COVID-19 treatments and prevention

Speeding the development of quality vaccines and treatments.

See how

Resources from USP Convention Member Organizations

Many of USP’s Convention Member Organizations are urgently working to address this public health crisis, applying their unique expertise to this challenge. Here are links to some of these resources. We’ll be adding others regularly.

USP's Ronald Piervincenzi and Mike Ganio from the American Society of Health System Pharmacists, discuss potential shortages of drugs made in China and India, and shipped throughout the world.

blue-gray

Poor-quality medical products erode trust in health systems. Professor Ashish Jha explains why protecting people from substandard and falsified medicines is particularly essential to protect global public health during disease outbreaks, like the coronavirus pandemic

blue-gray

Shortages of quality essential medicines during the COVID-19 pandemic are compromising our ability to save lives. Learn how USP India is responding to drug shortages and protecting public health.

blue-gray